L-768242
Modify Date: 2024-01-06 17:32:34
L-768242 structure
|
Common Name | L-768242 | ||
|---|---|---|---|---|
| CAS Number | 180002-83-9 | Molecular Weight | 447.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H24Cl2N2O3 | Melting Point | 47-49°C(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of L-768242GW-405833 (L768242) is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM. GW-405833 also behaves as a noncompetitive CB1 antagonist. GW-405833 suppresses inflammatory and neuropathic pain[1][2]. |
| Name | (2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone |
|---|---|
| Synonym | More Synonyms |
| Description | GW-405833 (L768242) is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM. GW-405833 also behaves as a noncompetitive CB1 antagonist. GW-405833 suppresses inflammatory and neuropathic pain[1][2]. |
|---|---|
| Related Catalog | |
| Target |
CB2:50.7 nM (EC50) CB1:16.1 μM (EC50) |
| References |
| Melting Point | 47-49°C(lit.) |
|---|---|
| Molecular Formula | C23H24Cl2N2O3 |
| Molecular Weight | 447.35 |
| Exact Mass | 446.11600 |
| PSA | 43.70000 |
| LogP | 4.76620 |
| Storage condition | 2-8°C |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.
Cell Death Dis. 4 , e664, (2013) The anti-tumoral effects of cannabinoids have been described in different tumor systems, including pancreatic adenocarcinoma, but their mechanism of action remains unclear. We used cannabinoids specif... |
|
|
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
Cell Death Dis. 2 , e152, (2011) Gemcitabine (GEM, 2',2'-difluorodeoxycytidine) is currently used in advanced pancreatic adenocarcinoma, with a response rate of < 20%. The purpose of our work was to improve GEM activity by addition o... |
| hms3268p12 |